Towards a sustainable rare disease and orphan drug ecosystem in Saudi Arabia: policy insights from a multi-stakeholder workshop
The recommended strategies to enhance RD and OD accessibility include multifaceted approaches, such as increasing medical education and awareness, accrediting and investing in expanding the number of centers of excellence for RD diagnosis and management, streamlining regulatory processes for OD approval and importation, fostering international collaborations for knowledge exchange and capacity building, and implementing national policies to improve the affordability and reimbursement of ODs. Stakeholder collaboration is crucial to overcome the accessibility challenges of RDs and ODs. The development of comprehensive national RD strategies ensures equitable resource allocation, a national RD registry, and infrastructure improvements. These measures are vital for ensuring equitable access to ODs and the efficient provision of healthcare services in SA.
Authors
- Ghada Abo-Zaid (ORCID: https://orcid.org/0000-0002-4523-0577)
- Amy Jayne McKnight (ORCID: https://orcid.org/0000-0002-7482-709X)
- Hussain Abdulrahman Al‐Omar (ORCID: https://orcid.org/0000-0002-0765-0466)
- Abdulrahman A. Al-Rabiah (ORCID: https://orcid.org/0000-0001-5213-3209)
- Asma A. Almuaither
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- King Saud University (SA)
- Saudi Center for Disease Prevention and Control (SA)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3389/fphar.2025.1583477
- Citations
- 2
- Primary Topic
- Biotechnology and Related Fields
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- UK Research and Innovation
- Princess Nourah Bint Abdulrahman University
- Medical Research Council
- Health and Social Care Research and Development Division